Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
Liver transplantation for hepatocellular carcinoma: the hepatitis C quandary.
Selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
